PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Valentin Fuster, MD, PhD, receives prestigious award from World Heart Federation

Valentin Fuster, MD, PhD, receives prestigious award from World Heart Federation
2024-05-28
(Press-News.org) The World Heart Federation (WHF) is honoring Valentin Fuster, MD, PhD, President of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, with its Lifetime Achievement Award for 2024. This top honor recognizes his remarkable contributions to the WHF mission, and to the entire cardiovascular disease community for his dedication to combating this disease worldwide.

The WHF will present Dr. Fuster with this award on Saturday, May 25, during the World Heart Summit in Geneva, Switzerland.

“I am proud of this award, particularly because it represents Mount Sinai’s worldwide scientific contributions and dedication to advancements in the cardiovascular field,” says Dr. Fuster.

Dr. Fuster is a pre-eminent leader in cardiovascular medicine. His contributions to the field, and to prevention and treatment of heart disease globally, are unparalleled. Dr. Fuster was named Director of the Cardiovascular Institute at Mount Sinai in 1994, became Director of Mount Sinai Heart at its establishment in 2006, and held that position until the end of 2022. He built what is now known as Mount Sinai Fuster Heart Hospital into one of the world’s leading centers for cardiovascular care, cardiac surgery, and advanced research. Dr. Fuster is also General Director of the Spanish National Center for Cardiovascular Research (CNIC).

Dr. Fuster also helped develop a cardiovascular “polypill”—a single pill that includes three medications typically taken separately—that is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack. Dr. Fuster and his team showed that the polypill reduces cardiovascular mortality by 33 percent in this population. This medication was recently included by the World Health Organization in its List of Essential Medicines and is pending Food and Drug Administration approval in the United States.

His research into the origin of cardiovascular events, which has contributed to improved treatment of heart attack patients, was recognized in 1996 by the Prince of Asturias Award for Technical and Scientific Research, the highest international award given by Dr. Fuster’s native Spain. In June 2011 he was awarded the Grand Prix Scientifique of the Institute of France for his translational research into atherothrombotic disease. Recently, he was named a Prince Mahidol Award Laureate in Thailand for his lifelong contribution to the field of medicine, and in 2022, the American College of Cardiology instituted the “Valentin Fuster Award in Science and Innovation,” which will be given to a single physician annually for the next 14 years.

Dr. Fuster has also received the highest awards for research from the four leading cardiovascular organizations: the American Heart Association (Gold Medal and Research Achievement Award), the American College of Cardiology (Living Legend and Life Achievement Award), the European Society of Cardiology (Gold Medal), and the Interamerican Society of Cardiology (Research Achievement Award). In May 2014, King Juan Carlos I of Spain granted Dr. Fuster the title of Marquis for his "outstanding and unceasing research efforts and his educational outreach work."

 

Mount Sinai is a World Leader in Cardiology and Heart Surgery

Mount Sinai Fuster Heart Hospital at The Mount Sinai Hospital ranks No. 1 in New York and No. 4 globally according to Newsweek’s “The World’s Best Specialized Hospitals.” It also ranks No. 1 in New York for cardiology, heart, and vascular surgery, according to U.S. News & World Report®.  

It is part of Mount Sinai Health System, which is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. We advance medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,400 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report's® “Best Hospitals” Honor Roll for 2023-2024.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

 

 

 

END

[Attachments] See images for this press release:
Valentin Fuster, MD, PhD, receives prestigious award from World Heart Federation

ELSE PRESS RELEASES FROM THIS DATE:

Nonlinear photochromic properties in a perylene-substituted rhodamine spirolactam

Nonlinear photochromic properties in a perylene-substituted rhodamine spirolactam
2024-05-28
Photochromic compounds, which change their color when exposed to light, have been widely used as photoswitches to control different properties of materials. Nonlinear photochromic compounds, characterized by a nonlinear response to the intensity of incident light, have attracted special attention among researchers as the nonlinearity leads to enhanced contrast and improved spatial resolution in photochromic reactions. It also allows for multiple photochromic properties in a single molecule with a single light source. These qualities have made them valuable in nonlinear optical and holographic elements, super-resolution microscopy, and biomedical applications. The simplest ...

Binge-eating disorder not as transient as previously thought

2024-05-28
BELMONT, Mass. (May 28, 2024) Binge-eating disorder is the most prevalent eating disorder in the United States, but previous studies have presented conflicting views of the disorder’s duration and the likelihood of relapse. A new five-year study led by  investigators from McLean Hospital, a member of the Mass General Brigham healthcare system, showed that 61 percent and 45 percent of individuals still experienced binge-eating disorder 2.5 and 5 years after their initial diagnoses, respectively. These results contradict previous ...

Pharmacists prove effective, less costly care option for minor illnesses

2024-05-28
SPOKANE, Wash. – Greater use of pharmacists to treat minor illnesses could potentially save millions of dollars in health care costs, according to new research led by Washington State University. The findings also indicate a way to improve healthcare access by expanding availability of pharmacists’ clinical services including prescribing medications, amid an ongoing shortage of primary care providers. The study found that care for a range of minor health issues – including urinary tract infections, shingles, animal bites and headaches – costs an average of about $278 less when treated in pharmacies compared to patients with similar ...

Inexpensive microplastic monitoring through porous materials and machine learning

Inexpensive microplastic monitoring through porous materials and machine learning
2024-05-28
Optical analysis and machine learning techniques can now readily detect microplastics in marine and freshwater environments using inexpensive porous metal substrates. Details of the method, developed by researchers at Nagoya University with collaborators at the National Institute for Materials Sciences in Japan and others, are published in the journal Nature Communications.  Detecting and identifying microplastics in water samples is essential for environmental monitoring but is challenging due in part to the structural similarity of microplastics with natural organic compounds derived from biofilms, algae, and decaying organic matter. Existing detection methods ...

Mystery of ‘slow’ solar wind unveiled by Solar Orbiter mission

Mystery of ‘slow’ solar wind unveiled by Solar Orbiter mission
2024-05-28
Scientists have come a step closer to identifying the mysterious origins of the ‘slow’ solar wind, using data collected during the Solar Orbiter spacecraft’s first close journey to the Sun. Solar wind, which can travel at hundreds of kilometres per second, has fascinated scientists for years, and new research published in Nature Astronomy, is finally shedding light on how it forms. Solar wind describes the continuous outflow of charged plasma particles from the Sun into space – with wind travelling at over 500km ...

Study suggests ‘biodegradable’ teabags don’t readily deteriorate in the environment and can adversely affect terrestrial species

2024-05-28
Some teabags manufactured using plastic alternatives do not degrade in soil and have the potential to harm terrestrial species, a new study has shown. The research looked at commonly available teabags made using three different compositions of polylactic acid (PLA), which is derived from sources such as corn starch or sugar cane. The teabags were buried in soil for seven months, and a range of techniques were then used to assess whether – and to what extent – they had deteriorated. The results showed that teabags made solely from PLA remained completely intact. However, the ...

Algorithms could help improve judicial decisions

2024-05-28
A new paper in the Quarterly Journal of Economics, published by Oxford University Press, finds that replacing certain judicial decision-making functions with algorithms could improve outcomes for defendants by eliminating some of the systemic biases of judges. Decision makers make consequential choices based on predictions of unknown outcomes. Judges, in particular, make decisions about whether to grant bail to defendants or how to sentence those convicted. Companies now use machine learning based models increasingly in high-stakes decisions. There are various assumptions about human behavior underlying the deployment of ...

Scientists uncover a multibillion-year epic written into the chemistry of life

Scientists uncover a multibillion-year epic written into the chemistry of life
2024-05-28
The origin of life on Earth has long been a mystery that has eluded scientists. A key question is how much of the history of life on Earth is lost to time. It is quite common for a single species to "phase out" using a biochemical reaction, and if this happens across enough species, such reactions could effectively be "forgotten" by life on Earth. But if the history of biochemistry is rife with forgotten reactions, would there be any way to tell? This question inspired researchers from the Earth-Life Science Institute (ELSI) at the Tokyo Institute of Technology, and the California Institute of Technology (CalTech) ...

Monitoring diseases through sweat becomes accessible to everyone

Monitoring diseases through sweat becomes accessible to everyone
2024-05-28
Sweat contains biomarkers that can monitor various health conditions, from diabetes to genetic disorders. Sweat sampling, unlike blood collection, is preferred by users due to its painless nature. However, to obtain sufficient nutrients or hormones from sweat for testing, intense physical activity was previously required to induce sweat. This method posed challenges for individuals with limited mobility. Dr. Kim Joohee from the Bionics Research Center at the Korea Institute of Science and Technology (KIST, Director Oh Sangrok) and Professor John A. Rogers from Northwestern University jointly announced the development ...

Mathematical model driven evolutionary therapy dosing exploiting cancer cell plasticity

Mathematical model driven evolutionary therapy dosing exploiting cancer cell plasticity
2024-05-28
Cancer poses significant challenges due to the development of resistance and the likelihood of relapse. Resistance may arise from permanent genetic changes in cancer cells or non-genetic alterations in cancer cell behavior induced by treatment. Standard of care in cancer treatments typically involves administering the maximum tolerated dose of a drug to eradicate drug-sensitive cells effectively. However, this approach often fails in the long term because drug-resistant cancer cells can grow more rapidly when all drug-sensitive cancer ...

LAST 30 PRESS RELEASES:

Rugged Falklands landscape was once a lush rainforest

Dizziness in older adults is linked to higher risk of future falls

Triptans more effective than newer, more expensive migraine drugs

Iron given through the vein corrects iron deficiency anaemia in pregnant women faster and better than iron taken by mouth

The Lancet Neurology: Air pollution, high temperatures, and metabolic risk factors driving global increases in stroke, with latest figures estimating 12 million cases and over 7 million deaths from st

Incidence of neuroleptic malignant syndrome during antipsychotic treatment in children and youth

Levels of protection from different cycle helmets revealed by new ratings

Pupils with SEND continue to fall behind their peers

Half of heavier drinkers say calorie labels on alcohol would lead to a change in their drinking habits

Study first to link operating room design to shorter surgery

New study uncovers therapeutic inertia in the treatment of women with multiple sclerosis

Cancer Cooperative Group leaders propose a re-engineering of the nation’s correlative science program for cancer

Nawaz named ASME Fellow

U2opia signs license to commercialize anomaly-detection technology for cybersecurity

Explaining dramatic planetwide changes after world’s last ‘Snowball Earth’ event

Cleveland Clinic study is first to show success in treating rare blood disorder

Bone marrow cancer drug shows success in treatment of rare blood disorder

Clinical trial successfully repurposes cancer drug for hereditary bleeding disorder

UVA Engineering professor awarded $1.6M EPA grant to reduce PFAS accumulation in crops

UVA professor receives OpenAI grant to inform next-generation AI systems

New website helps researchers overcome peer reviewers’ preference for animal experiments

Can the MIND diet lower the risk of memory problems later in life?

Some diabetes drugs tied to lower risk of dementia, Parkinson’s disease

Propagated corals reveal increased resistance to bleaching across the Caribbean during the fatal heatwave of 2023

South African rock art possibly inspired by long-extinct species

Even marine animals in untouched habitats are at risk from human impacts

Hexagonal electrohydraulic modules shape-shift into versatile robots

Flexible circuits made with silk and graphene on the horizon

Scott Emr and Wesley Sundquist awarded 2024 Horwitz Prize for discovering the ESCRT pathway

Versatile knee exo for safer lifting

[Press-News.org] Valentin Fuster, MD, PhD, receives prestigious award from World Heart Federation